Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019;57(2):91-99.
doi: 10.5114/reum.2019.84814. Epub 2019 Apr 29.

Determination of antibodies in everyday rheumatological practice

Affiliations
Review

Determination of antibodies in everyday rheumatological practice

Katarzyna Napiórkowska-Baran et al. Reumatologia. 2019.

Abstract

Antibody determination is routinely used in everyday rheumatological practice. Its result repeatedly determines the diagnosis or exclusion of a particular disease. Antibodies are immunoglobulins, i.e. some of the most important proteins in the immune system, and have specific properties that we should know. In addition, there are a number of factors that can affect their concentration, including drugs commonly used in the treatment of rheumatic diseases. There are definite indications, when the total concentrations of individual classes of immunoglobulins should be initially determined and it should be evaluated whether the patient produces them at all or their production is impaired. In some cases, we should evaluate the levels of specific antibodies along with the total protein concentration and the γ-globulin fraction, in which the antibodies are contained. The article presents information on the most common mistakes made when performing these tests.

Keywords: antibodies; immunoglobulins; rheumatic diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Yazdani R, Azizi G, Abolhassani H, et al. Selective IgA Deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management. Scand J Immunol. 2017;85:3–12. - PubMed
    1. Novaretti MCZ, Dinardo CL. ImmunoglobulIn: production, mechanisms of action and formulations. Rev Bras Hematol Hemoter. 2011;33:377–382. - PMC - PubMed
    1. Pierpont TM, Limper CB, Richards KL. Past, Present, and Future of Rituximab-The World’s First Oncology Monoclonal Antibody Therapy. Front Oncol. 2018;8:163. - PMC - PubMed
    1. Vollmar A, Zündorf I, Dingermann T. Immunologie Grundlagen und Wirkstoffe. Die erworbene Immunantwort. Hauptakteure. Lösliche Faktoren. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2012.
    1. Schroeder HW, Jr, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010;125(Suppl 2):S41–S52. - PMC - PubMed

LinkOut - more resources